For the first time ever, a patient will fight lung cancer with CRISPR-edited cells

The first CRISPR trial in humans took place in China

For the first time ever, Chinese scientists have injected a person with cells that have been tweaked by the genome-editing technique CRISPR, Nature reports. The procedure was part of a clinical trial led by oncologist Lu You at the West China Hospital in Chengdu; it involved editing immune cells from a patient with aggressive lung cancer and then injecting them back into the patient to help defeat the disease.

Trials with modified cells have been run before. But this is the first time that scientists are using cells edited with CRISPR — a genetic copy-and-paste tool that makes modifying cells easier and cheaper. The technique can allow scientists to make cells grow and multiply faster, in addition to inserting instructions to kill cancer on sight. A trial with CRISPR-edited cells is expected to begin early next year in the US to treat various types of cancers.

In China, the researchers took immune cells from the patient’s blood and then used CRISPR to disable a gene that slows down the cell’s immune response. Cancer takes advantage of that weakness to spread. The researchers then multiplied the edited cells and injected them back into the patient. The hope is that these new cells will help the patient defeat lung cancer. Lu told Nature that the first injection went well and the patient will receive a second one, but he didn’t provide more details.

Lu, who received ethical approval for the trial in July, says he plans to treat 10 people with CRISPR-edited cells. The patients will be monitored for over six months to see whether the injections are safe. Even if the trails are successful, they’re very small to determine whether the CRISPR-edited immune cells will be the new tool against cancer. But the research is promising.

Some have objected to altering human genes with CRISPR, but the cells edited in this clinical trial are considered less of an ethical gray area because they won’t be passed down to offspring. The patients will be the only one feeling the effects of the edited immune cells.

Comments

The Secret Science 02:The 30 Most Disturbing Human Experiments in History

Disturbing human experiments aren’t something the average person thinks too much about. Rather, the progress achieved in the last 150 years of human history is an accomplishment we’re reminded of almost daily. Achievements made in fields like biomedicine and psychology mean that we no longer need to worry about things like deadly diseases or masturbation as a form of insanity. For better or worse, we have developed more effective ways to gather information, treat skin abnormalities, and even kill each other. But what we are not constantly reminded of are the human lives that have been damaged or lost in the name of this progress. The following is a list of the 30 most disturbing human experiments in history. 30. The Tearoom Sex Study Sociologist Laud Humphreys often wondered about the men who commit impersonal sexual acts with one another in public restrooms. He wondered why “tearoom sex” — fellatio in public restrooms — led to the majority of homosexual arrests in ...

The Strange and Stranger Case of Wyndham Lathem

A Northwestern University plague researcher has been charged with a brutal murder. Here’s what we know about him. WIKIMEDIA, TONY WEBSTER O n July 27, The Chicago Tribune reported that there was an arrest warrant issued for Wyndham Lathem , a microbiologist at Northwestern University. The crime Lathem would later be charged with was brutal—26-year-old Trenton James Cornell-Duranleau, whose body was found in Lathem’s apartment, had been stabbed dozens of times. But Lathem was nowhere to be found. As events unfolded over the following days, it became clear he had fled from Chicago to California with a second suspect, 56-year-old Andrew Warren, a University of Oxford employee from the United Kingdom visiting the states. Along the way, the two men apparently made an anonymous $1,000 donation in Cornell-Duranleau’s name to the Lake Geneva Public Library and another donation for $5,610 to a Chicago health center. Lathem had also sent a video to fa...

Popular painkiller doesn’t have more heart risks than others, study claims

NEW ORLEANS — A long-awaited study on painkillers called nonsteroidal anti-inflammatory drugs, the most widely prescribed class of drugs in the world, has concluded that the three most commonly used carry a similar risk of cardiovascular complications. Yet critics say the study was too flawed to fairly compare them. Concerns about a type of NSAID called COX-2 inhibitors peaked in 2004 when the drug Vioxx was withdrawn from the market — a decision steeped in scandal because manufacturer Merck & Co had initially hidden data that would reveal the drug’s cardiovascular risks. A second COX-2 inhibitor, Pfizer Inc.’s Celebrex, was allowed to remain on the market with the condition that Pfizer conduct a study to prove that Celebrex was no worse than two older NSAIDs, naproxen and ibuprofen. The study lasted 10 years and enrolled more than 24,000 patients, but faced challenges. Doctors in European Union countries would not participate because they were worried a...

The Research

Search This Blog